Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-028024
Filing Date
2013-05-10
Accepted
2013-05-10 17:09:38
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v343570_10q.htm 10-Q 353051
2 EXHIBIT 31.1 v343570_ex31-1.htm EX-31.1 9950
3 EXHIBIT 32.1 v343570_ex32-1.htm EX-32.1 3852
  Complete submission text file 0001144204-13-028024.txt   2205453

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT innv-20130331.xml EX-101.INS 178726
5 XBRL TAXONOMY EXTENSION SCHEMA innv-20130331.xsd EX-101.SCH 33778
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE innv-20130331_cal.xml EX-101.CAL 17947
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE innv-20130331_def.xml EX-101.DEF 142053
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE innv-20130331_lab.xml EX-101.LAB 213853
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE innv-20130331_pre.xml EX-101.PRE 167427
Mailing Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

EIN.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52991 | Film No.: 13834463
SIC: 6770 Blank Checks